p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

YS Bian, MC Osterheld, C Fontolliet, FT Bosman… - Gastroenterology, 2002 - Elsevier
BACKGROUND & AIMS:: The potential role of p16 inactivation by CDKN2A/p16 promoter
hypermethylation and/or loss of heterozygosity (LOH) of the CDKN2A gene was investigated …
被引用次数：234 相关文章

p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

YS Bian, MC Osterheld, C Fontolliet… - …, 2002 - pubmed.ncbi.nlm.nih.gov
Background & aims The potential role of p16 inactivation by CDKN2A/p16 promoter
hypermethylation and/or loss of heterozygosity (LOH) of the CDKN2A gene was investigated …

[引用][C] p16 Inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

YS Bian, MC Osterheld, C Fontolliet, FT Bosman… - Gastroenterology, 2002 - cir.nii.ac.jp
p16 Inactivation by methylation of the CDKN2A promoter occurs early during neoplastic
progression in Barrett's esophagus | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

p16 Inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

YS Bian, MC Osterheld, C Fontolliet, FT Bosman… - Gastroenterology, 2002 - infona.pl
Background & Aims: The potential role of p16 inactivation by CDKN2A/p16 promoter
hypermethylation and/or loss of heterozygosity (LOH) of the CDKN2A gene was investigated …

p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.

YS Bian, MC Osterheld, C Fontolliet, FT Bosman… - …, 2002 - europepmc.org
Methods CDKN2A promoter hypermethylation was studied by methylation sensitive single-
strand conformation analysis and sequencing using bisulfite modified DNA in Barrett's …

p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.

YS Bian, MC Osterheld, C Fontolliet, FT Bosman… - …, 2002 - folia.unifr.ch
METHODS CDKN2A promoter hypermethylation was studied by methylation sensitive single-
strand conformation analysis and sequencing using bisulfite modified DNA in Barrett's …

[引用][C] p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

YS BIAN, MC OSTERHELD… - … (New York, NY …, 2002 - pascal-francis.inist.fr
p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic
progression in Barrett's esophagus CNRS Inist Pascal-Francis CNRS Pascal and Francis …

p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.

YS Bian, MC Osterheld, C Fontolliet, FT Bosman… - Gastroenterology, 2002 - sonar.ch
METHODS CDKN2A promoter hypermethylation was studied by methylation sensitive single-
strand conformation analysis and sequencing using bisulfite modified DNA in Barrett's …

p16 Inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

YS Bian, MC Osterheld, C Fontolliet, FT Bosman… - …, 2002 - gastrojournal.org
Abstract Background & Aims: The potential role of p16 inactivation by CDKN2A/p16
promoter hypermethylation and/or loss of heterozygosity (LOH) of the CDKN2A gene was …

[引用][C] p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

YS BIAN, MC OSTERHELD, C FONTOLLIET… - Gastroenterology, 2002 - Wiley